Picture of Stayble Therapeutics AB logo

STABL Stayble Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 3.8 Mln

May 23 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * Q1 EBIT LOSS SEK 3.8 MILLION VERSUS LOSS SEK 7.5 MILLION
YEAR
AGO
    * Q1 NET LOSS SEK 3.7 MILLION VERSUS LOSS SEK 7.6 MILLION
YEAR AGO

Source text for Eikon:  ID:nWkrjW9jY 
Further company coverage:  STABL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Stayble Therapeutics AB

See all news